MDS International Prognostic Scoring System (IPSS)

Determine prognosis in myelodysplastic sydnrome


Myelodysplastic syndromes are a heterogeneous group of diseases with variable outcomes. Patients with low-risk disease often have longer survivals and the primary therapeutic goals include improvement of ineffective hematopoiesis and reduction of iron overload. Higher risk patients are managed with the goal of delaying transformation to acute leukemia and extending survival. The International Prognostic Scoring System is the most commonly used tool in MDS to predict long-term outcome.

By using this site you acknowledge that you have read, understand, and agree to be bound by our terms of use and privacy policy. All content and tools are for educational use only, are not meant to be a substitute for professional advice and should not be used for medical diagnosis and/or medical treatment.

1. BM Blasts?

0/3 completed